Ottawa - It’s a document you’d be forgiven for not knowing exists, but for those in the know, today’s arrival of CADTH’s fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada is highly anticipated in Canada and abroad.
This set of guidelines from CADTH, which stands for the Canadian Agency for Drugs and Tech...
The 2017 CADTH Symposium program has been updated with new sessions, including:
The Role of Artificial Intelligence In Canada’s Health Care Sector
Incorporating Indigenous Perspectives into Health Technology Management
INESSS: Improving the Value of Health Care by Combining Knowledge-Based Evidence With Real-World Experience
New Innovations in ...
Join us in person or online on Tuesday, March 28, 2017 as we release the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada.
This release marks the first update to the Guidelines since the third edition was published in 2006.
The Guidelines are intended to help produce credible and standardized economic i...
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
1. Expanding CADTH’s Drug Review Processes to Include Radiopharmaceuticals
In collaboration with the participating jurisdictions, CADTH is pleased to announce that CADTH will accept submissions for radiopharmaceuticals used for therapeutic purposes (i.e., not for diagnostic purposes) for review through the CADTH Common Drug Review (CDR) and the ...